CRISPR Therapeutics (CRSP)

CRISPR Therapeutics (CRSP) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CRSP last traded at $49.92, -2.92% on the day.
• CRISPR Therapeutics: market cap $4.97B, P/E -10.5, revenue $13.39M over the last four quarters, next earnings 2026-11-09.
• Over the past year CRSP returned -18.30%; year to date -4.81%.

Updated 2026-11-02 19:09 UTC